Vobe-Mugos E
Producer: Mucos Pharma GmbH & Co (Mukos Pharm Gmbh and To) Germany
Code of automatic telephone exchange: L01XX
Release form: Firm dosage forms. Tablets.
General characteristics. Structure:
Active ingredients: 40 mg of chymotrypsin, 40 mg of trypsin, 100 mg of papain.
Excipients: lactose, cellulose microcrystallic, macrogoal 6000, коповидон, magnesium stearate, silicon dioxide anhydrous, povidone, кросповидон, copolymer of methacrylic acid and methylmethacrylate (1:1), talc, triethyl citrate, vanillin.
Pharmacological properties:
Pharmacodynamics. Enzymes (enzymes) take part in implementation practically of all processes of life activity of an organism.
VOBE-MUGOS E ® represents a combination of highly active natural enzymes of an animal and plant origin. Possesses immunomodulatory, fibrinoliticheeky, antiinflammatory action. Activates virus-induced immunity (NK cells, cytotoxic T lymphocytes, macrophages) and regulates system of cytokines. Reduces negative impact beam and chemotherapy by an organism.
Splits cell-bound immune complexes and promotes their elimination due to stimulation of phagocytal activity of macrophages.
Improves rheological properties of blood and microcirculation that promotes removal of toxic products and improvement of a trophicity of fabrics.
Indications to use:
Treatment of herpes infections:
- Shingles, herpes simplex, and also their recurrent forms. In complex therapy as supportive application for reduction of side effects химио and radiation therapy.
Route of administration and doses:
It is necessary to take a pill not less, than in 30 minutes prior to food, without chewing, washing down with water (150-200 ml).
At treatment of viral diseases, about 3-5 tablets 3 times a day before disappearance of the main clinical symptoms are recommended to accept. At a heavy herpes infection it is necessary to accept drug on 5 tablets 3 times a day, within 2-4 weeks and more before disappearance of the main clinical symptoms. Duration of a course of treatment is defined by the doctor individually. In the first day of administration of drug the recommended dose makes 2 tablets 3 times a day.
Attention! Treatment should be begun as soon as possible - at emergence of the first symptoms of a viral infection. During a course himio-or radiation therapy about 3 tablets 3 times a day during all course of therapy are recommended to accept. If necessary it is possible to increase a dose of drug to 5 tablets 3 times a day.
Features of use:
In the initiation of treatment drug symptoms of a disease can become aggravated that should be regarded as reaction of an organism to therapy. In such cases administration of drug should not be interrupted, the temporary dose decline is recommended.
Drug does not exert a negative impact on driving of the car and performance of work, the mental and physical reactions demanding high speed.
Side effects:
VOBE-MUGOS E ® is usually well transferred by patients, side effects were not observed even at prolonged treatment by high doses. Lighter coloring of a chair, change of a smell and consistence is in some cases noted.
At reception of high doses of drug, the feeling of abdominal distention, and increase of a chair is sometimes noted. In these cases administration of drug should not be interrupted, the temporary dose decline is recommended.
Interaction with other medicines:
At a concomitant use with other drugs cases of incompatibility are unknown.
Contraindications:
The diseases which are followed by disturbances of coagulability of blood (hemophilia) and also when carrying out a hemodialysis.
With care - during pregnancy.
Overdose:
Cases of overdose of drug are unknown.
Storage conditions:
List B. In the dry place at a temperature of 15-25 °C in the place, unavailable to children. Period of validity 2 years.
Issue conditions:
According to the recipe
Packaging:
The tablets covered with a kishechnorastvorimy cover (blisters) on, 20 pieces, contain in boxes on 20, 40 and 100 pieces with instructions on a medical use.